Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Other Receivables
Prestige Consumer Healthcare Inc
Other Receivables Peer Comparison
Competitive Other Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Receivables
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Receivables
$4.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
Pfizer Inc
NYSE:PFE
|
Other Receivables
$4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Other Receivables
$744m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Receivables
$2.1B
|
CAGR 3-Years
26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
11%
|
See Also
What is Prestige Consumer Healthcare Inc's Other Receivables?
Other Receivables
0
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Other Receivables amounts to 0 USD.